Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 74

Similar articles for PubMed (Select 23411097)

1.

Macrophage migration inhibitory factor is necessary for the lipo-oligosaccharide-induced response by modulation of Toll-like receptor 4 in monocytes from GBS patients.

Wang YZ, Tian FF, Liu H, Zhang W, Li J, Xiao B, Zhou WB.

J Neuroimmunol. 2013 Apr 15;257(1-2):67-75. doi: 10.1016/j.jneuroim.2013.01.006. Epub 2013 Feb 12.

PMID:
23411097
2.

TLR4-mediated sensing of Campylobacter jejuni by dendritic cells is determined by sialylation.

Kuijf ML, Samsom JN, van Rijs W, Bax M, Huizinga R, Heikema AP, van Doorn PA, van Belkum A, van Kooyk Y, Burgers PC, Luider TM, Endtz HP, Nieuwenhuis EE, Jacobs BC.

J Immunol. 2010 Jul 1;185(1):748-55. doi: 10.4049/jimmunol.0903014. Epub 2010 Jun 4.

3.

Expression of Toll-like receptors 2, 4 and 9 in patients with Guillain-Barré syndrome.

Wang YZ, Liang QH, Ramkalawan H, Wang YL, Yang YF, Zhou WB, Tian FF, Li J, Yang H.

Neuroimmunomodulation. 2012;19(1):60-8. doi: 10.1159/000328200. Epub 2011 Nov 7.

PMID:
22067623
4.

Macrophage migration inhibitory factor (MIF) seems crucially involved in Guillain-Barré syndrome and experimental allergic neuritis.

Nicoletti F, Créange A, Orlikowski D, Bolgert F, Mangano K, Metz C, Di Marco R, Al Abed Y.

J Neuroimmunol. 2005 Nov;168(1-2):168-74.

PMID:
16171874
5.

Heme oxygenase-1 upregulation improves lipopolysaccharide-induced acute lung injury involving suppression of macrophage migration inhibitory factor.

Yin H, Li X, Gong Q, Jin X, Gu H, Yuan B, Zhang B, Zheng F, Gong F, Zhu J.

Mol Immunol. 2010 Sep;47(15):2443-9. doi: 10.1016/j.molimm.2010.06.013. Epub 2010 Jul 16.

PMID:
20638132
6.

Differential and cell-type specific regulation of responses to Toll-like receptor agonists by ISO-1.

West PW, Parker LC, Ward JR, Sabroe I.

Immunology. 2008 Sep;125(1):101-10. doi: 10.1111/j.1365-2567.2008.02825.x. Epub 2008 Mar 18.

7.

Comprehensive analysis of bacterial risk factors for the development of Guillain-Barre syndrome after Campylobacter jejuni enteritis.

Koga M, Gilbert M, Takahashi M, Li J, Koike S, Hirata K, Yuki N.

J Infect Dis. 2006 Feb 15;193(4):547-55. Epub 2006 Jan 19.

8.

Role for macrophage migration inhibitory factor in acute respiratory distress syndrome.

Lai KN, Leung JC, Metz CN, Lai FM, Bucala R, Lan HY.

J Pathol. 2003 Apr;199(4):496-508.

PMID:
12635141
9.

Regulation of Toll-like receptor 4 expression in mouse colon by macrophage migration inhibitory factor.

Ohkawara T, Takeda H, Miyashita K, Nishiwaki M, Nakayama T, Taniguchi M, Yoshiki T, Tanaka J, Imamura M, Sugiyama T, Asaka M, Nishihira J.

Histochem Cell Biol. 2006 May;125(5):575-82. Epub 2005 Dec 7. Erratum in: Histochem Cell Biol. 2006 May;125(5):603. Takana, Junji [corrected to Tanaka, Junji].

PMID:
16283355
10.

Macrophage migration inhibitory factor (MIF) is necessary for progression of autoimmune diabetes mellitus.

Stosic-Grujicic S, Stojanovic I, Maksimovic-Ivanic D, Momcilovic M, Popadic D, Harhaji L, Miljkovic D, Metz C, Mangano K, Papaccio G, Al-Abed Y, Nicoletti F.

J Cell Physiol. 2008 Jun;215(3):665-75.

PMID:
18064633
11.

Campylobacter coli enteritis and Guillain-Barré syndrome: no evidence of molecular mimicry and serological relationship.

Funakoshi K, Koga M, Takahashi M, Hirata K, Yuki N.

J Neurol Sci. 2006 Jul 15;246(1-2):163-8.

PMID:
16600306
12.

Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis.

Iwahashi M, Yamamura M, Aita T, Okamoto A, Ueno A, Ogawa N, Akashi S, Miyake K, Godowski PJ, Makino H.

Arthritis Rheum. 2004 May;50(5):1457-67.

13.

Sex steroid regulation of macrophage migration inhibitory factor in normal and inflamed colon in the female rat.

Houdeau E, Moriez R, Leveque M, Salvador-Cartier C, Waget A, Leng L, Bueno L, Bucala R, Fioramonti J.

Gastroenterology. 2007 Mar;132(3):982-93. Epub 2006 Dec 17.

PMID:
17324399
14.

Macrophage migration inhibitory factor is essential for allergic asthma but not for Th2 differentiation.

Magalhães ES, Mourao-Sa DS, Vieira-de-Abreu A, Figueiredo RT, Pires AL, Farias-Filho FA, Fonseca BP, Viola JP, Metz C, Martins MA, Castro-Faria-Neto HC, Bozza PT, Bozza MT.

Eur J Immunol. 2007 Apr;37(4):1097-106.

PMID:
17373669
15.
16.

MIF regulates innate immune responses through modulation of Toll-like receptor 4.

Roger T, David J, Glauser MP, Calandra T.

Nature. 2001 Dec 20-27;414(6866):920-4.

PMID:
11780066
17.

Expression of macrophage migration inhibitory factor and CD74 in cervical squamous cell carcinoma.

Cheng RJ, Deng WG, Niu CB, Li YY, Fu Y.

Int J Gynecol Cancer. 2011 Aug;21(6):1004-12. doi: 10.1097/IGC.0b013e31821c45b7.

PMID:
21792010
18.

Role for IL-10 in inducing functional impairment of monocytes upon TLR4 ligation in patients with chronic HCV infections.

Liu BS, Groothuismink ZM, Janssen HL, Boonstra A.

J Leukoc Biol. 2011 Jun;89(6):981-8. doi: 10.1189/jlb.1210680. Epub 2011 Mar 8.

19.

Macrophage migration inhibitory factor, Toll-like receptor 4, and CD14 polymorphisms with altered expression levels in patients with ulcerative colitis.

Sivaram G, Tiwari SK, Bardia A, Anjum F, Vishnupriya S, Habeeb A, Khan AA.

Hum Immunol. 2012 Feb;73(2):201-5. doi: 10.1016/j.humimm.2011.12.006. Epub 2011 Dec 8.

PMID:
22192785
20.

Inhibition of macrophage migration inhibitory factor or its receptor (CD74) attenuates growth and invasion of DU-145 prostate cancer cells.

Meyer-Siegler KL, Iczkowski KA, Leng L, Bucala R, Vera PL.

J Immunol. 2006 Dec 15;177(12):8730-9.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk